Meta-Analysis
Copyright ©The Author(s) 2024.
World J Gastroenterol. Aug 28, 2024; 30(32): 3766-3782
Published online Aug 28, 2024. doi: 10.3748/wjg.v30.i32.3766
Table 1 The mechanism of mesenchymal stem cells combined with different drugs to improve the therapeutic effect of liver fibrosis
Ref.
Type of MSCs
Combination drugs
Mechanism
Ouyang et al[17], 2010BM-MSCsSalidrosidePromoting MSCs differentiation; the expression of TGF-β1 was inhibited
Chai et al[7], 2013BM-MSCsOxymatrineRegulating the inflammatory microenvironment
Motawi et al[22], 2014BM-MSCsSimvastatinAttributed to their effect on the MMPs/TIMPs balance
Hammam et al[16], 2016WJ-MSCsPraziquantelPromoting the differentiation of MSCs into functional hepatocytes
Jang et al[19], 2018BM-MSCsSimvastatinInhibition of TGF-β/Smad signaling pathway
Fathy et al[13], 2020AT-MSCsEugenolInhibition of TGF-β/Smad signaling pathway
Mazhari et al[12], 2020BM-MSCsImatinibBlocking PDGF signaling pathway
El-Monem et al[14], 2021BM-MSCsNano curcuminReducing TGFβ1 levels and attenuating the expression of Smad 2,3 and collagen I, III genes
Qiao et al[23], 2011PD-MSCsBaicalinPromoting the differentiation of MSCs into functional hepatocytes
Iwasawa et al[20], 2021BM-MSCsJuzentaihotoInducing the production of Treg cells and anti-inflammatory macrophages
Zhang et al[15], 2022BM-MSCsFerulic acidInhibition of HSCs activation
Rafiq et al[21], 2022BM-MSCsMelatonPromoting MSCs homing
Slautin et al[18], 2024PD-MSCsFucoxanthinDecreasing the proinflammatory cytokine levels, TGF-β level, α-SMA+, TIMP-1+ areas and increasing HGF level, MMP-13+, and MMP-9+ areas